Maxigen Biotech Inc.

TWSE:1783 Rapporto sulle azioni

Cap. di mercato: NT$4.0b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Maxigen Biotech Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Ching-Ting Chen

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO2.9yrs
Proprietà del CEO0.1%
Durata media del managementNessun dato
Durata media del Consiglio di amministrazione3.1yrs

Aggiornamenti recenti sulla gestione

Recent updates

Maxigen Biotech's (TWSE:1783) Earnings Are Of Questionable Quality

Mar 28
Maxigen Biotech's (TWSE:1783) Earnings Are Of Questionable Quality

Maxigen Biotech Inc. (TPE:1783) Is Yielding 2.3% - But Is It A Buy?

Apr 22
Maxigen Biotech Inc. (TPE:1783) Is Yielding 2.3% - But Is It A Buy?

We Think You Should Be Aware Of Some Concerning Factors In Maxigen Biotech's (TPE:1783) Earnings

Apr 01
We Think You Should Be Aware Of Some Concerning Factors In Maxigen Biotech's (TPE:1783) Earnings

Maxigen Biotech Inc.'s (TPE:1783) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Mar 16
Maxigen Biotech Inc.'s (TPE:1783) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

The Maxigen Biotech (TPE:1783) Share Price Has Gained 22% And Shareholders Are Hoping For More

Feb 23
The Maxigen Biotech (TPE:1783) Share Price Has Gained 22% And Shareholders Are Hoping For More

Can Maxigen Biotech (TPE:1783) Continue To Grow Its Returns On Capital?

Feb 02
Can Maxigen Biotech (TPE:1783) Continue To Grow Its Returns On Capital?

Tread With Caution Around Maxigen Biotech Inc.'s (TPE:1783) 3.4% Dividend Yield

Jan 10
Tread With Caution Around Maxigen Biotech Inc.'s (TPE:1783) 3.4% Dividend Yield

Declining Stock and Decent Financials: Is The Market Wrong About Maxigen Biotech Inc. (TPE:1783)?

Dec 14
Declining Stock and Decent Financials: Is The Market Wrong About Maxigen Biotech Inc. (TPE:1783)?

If You Had Bought Maxigen Biotech's (TPE:1783) Shares Five Years Ago You Would Be Down 13%

Nov 22
If You Had Bought Maxigen Biotech's (TPE:1783) Shares Five Years Ago You Would Be Down 13%

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Ching-Ting Chen rispetto agli utili di Maxigen Biotech?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

NT$147m

Mar 31 2024n/an/a

NT$150m

Dec 31 2023n/an/a

NT$166m

Sep 30 2023n/an/a

NT$191m

Jun 30 2023n/an/a

NT$192m

Mar 31 2023n/an/a

NT$163m

Dec 31 2022n/an/a

NT$139m

Sep 30 2022n/an/a

NT$110m

Jun 30 2022n/an/a

NT$99m

Mar 31 2022n/an/a

NT$87m

Dec 31 2021NT$1mNT$540k

NT$88m

Compensazione vs Mercato: Dati insufficienti per stabilire se la retribuzione totale di Ching-Ting sia ragionevole rispetto ad aziende di dimensioni simili nel mercato TW.

Compensazione vs guadagni: Dati insufficienti per confrontare la retribuzione di Ching-Ting con le performance aziendali.


AMMINISTRATORE DELEGATO

Ching-Ting Chen

2.9yrs

Mandato

NT$1,322,000

Compensazione

Ms. Ching-Ting Chen is Institutional Director of TCI Co. Ltd. from June 25, 2024 and serves as Head of Research & Design Center since February 5, 2020. She is General manager of TCI CO., Ltd.She has been...


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Ching-Ting Chen
GM & Representative Director2.8yrsNT$1.32m0.11%
NT$ 4.5m
Yung-Hsiang Lin
Chairman of the Board3.1yrsNessun datoNessun dato
Tsiu-Yuan Li
Representative Director9.2yrsNessun datoNessun dato
Chen-Chen Fu
Representative Director3.1yrsNessun datoNessun dato
Song Yuan Liao
Independent Director3.1yrsNessun datoNessun dato
Shi-Ming Li
Independent Director3.1yrsNessun datoNessun dato
Zeng Zhong Ming
Independent Director3.1yrsNessun datoNessun dato
Tsong-Jieh Chiou
Directorno dataNessun datoNessun dato
Shih-Ming Lai
Directorno dataNessun datoNessun dato

3.1yrs

Durata media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 1783 sono considerati esperti (durata media dell'incarico 3.1 anni).